Multi Tumor-Associated Antigen-Specific T Lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Multi Tumor-Associated Antigen-Specific T Lymphocytes, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors [Phase 1]